273 related articles for article (PubMed ID: 30179533)
21. A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2016-2017.
Dai H; Richter KP
JAMA Netw Open; 2019 Sep; 2(9):e1911936. PubMed ID: 31539078
[TBL] [Abstract][Full Text] [Related]
22. Subgroup trends in alcohol and cannabis co-use and related harms during the rollout of recreational cannabis legalization in Washington state.
Subbaraman MS; Kerr WC
Int J Drug Policy; 2020 Jan; 75():. PubMed ID: 31351754
[TBL] [Abstract][Full Text] [Related]
23. Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.
Hoffenberg EJ; Newman H; Collins C; Tarbell S; Leinwand K
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):265-271. PubMed ID: 27579692
[TBL] [Abstract][Full Text] [Related]
24. Correlates of Marijuana Drugged Driving and Openness to Driving While High: Evidence from Colorado and Washington.
Davis KC; Allen J; Duke J; Nonnemaker J; Bradfield B; Farrelly MC; Shafer P; Novak S
PLoS One; 2016; 11(1):e0146853. PubMed ID: 26800209
[TBL] [Abstract][Full Text] [Related]
25. Patterns and correlates of workplace and non-workplace cannabis use among Canadian workers before the legalization of non-medical cannabis.
Carnide N; Lee H; Frone MR; Furlan AD; Smith PM
Drug Alcohol Depend; 2021 Jan; 218():108386. PubMed ID: 33213975
[TBL] [Abstract][Full Text] [Related]
26. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
27. Cannabis use, use frequency, and use disorder in large metropolitan, small metropolitan, and nonmetropolitan areas.
Moore JR; Chen Q; Choi NG
Drug Alcohol Depend; 2021 Apr; 221():108631. PubMed ID: 33647587
[TBL] [Abstract][Full Text] [Related]
28. Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users.
Gibson LP; Hitchcock LN; Bryan AD; Bidwell LC
Complement Ther Med; 2021 Jan; 56():102619. PubMed ID: 33227352
[TBL] [Abstract][Full Text] [Related]
29. Social factors in marijuana use for medical and recreational purposes.
Szaflarski M; Sirven JI
Epilepsy Behav; 2017 May; 70(Pt B):280-287. PubMed ID: 28132734
[TBL] [Abstract][Full Text] [Related]
30. Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the United States: A Systematic Review.
French MT; Zukerberg J; Lewandowski TE; Piccolo KB; Mortensen K
Med Care Res Rev; 2022 Dec; 79(6):743-771. PubMed ID: 35068253
[TBL] [Abstract][Full Text] [Related]
31. Availability of and Participation in Workplace Health Promotion Programs by Sociodemographic, Occupation, and Work Organization Characteristics in US Workers.
Tsai R; Alterman T; Grosch JW; Luckhaupt SE
Am J Health Promot; 2019 Sep; 33(7):1028-1038. PubMed ID: 31014070
[TBL] [Abstract][Full Text] [Related]
32. Cannabis Use for Medicinal Purposes among Canadian University Students.
Smith JM; Mader J; Szeto ACH; Arria AM; Winters KC; Wilkes TCR
Can J Psychiatry; 2019 May; 64(5):351-355. PubMed ID: 30602305
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
Hall W; Lynskey M
Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.
Shi Y
Addiction; 2021 Jul; 116(7):1782-1793. PubMed ID: 33217090
[TBL] [Abstract][Full Text] [Related]
35. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
Leos-Toro C; Shiplo S; Hammond D
Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
[TBL] [Abstract][Full Text] [Related]
36. Self-reported driving after marijuana use in association with medical and recreational marijuana policies.
Benedetti MH; Li L; Neuroth LM; Humphries KD; Brooks-Russell A; Zhu M
Int J Drug Policy; 2021 Jun; 92():102944. PubMed ID: 33268196
[TBL] [Abstract][Full Text] [Related]
37. Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain.
Boehnke KF; Scott JR; Litinas E; Sisley S; Clauw DJ; Goesling J; Williams DA
J Pain; 2019 Nov; 20(11):1362-1372. PubMed ID: 31132510
[TBL] [Abstract][Full Text] [Related]
38. Cannabis use prevalence among individuals with diabetes: The National Survey on Drug Use and Health, 2005-2018.
Sexton TR; Alshaarawy O
Drug Alcohol Depend; 2020 Jul; 212():108035. PubMed ID: 32470752
[TBL] [Abstract][Full Text] [Related]
39. Assessing the prevalence and risk factors of marijuana use in adults with disabilities.
Gimm G; Parekh T; Kitsantas P
Addict Behav; 2023 Mar; 138():107559. PubMed ID: 36459827
[TBL] [Abstract][Full Text] [Related]
40. Marijuana legalization and historical trends in marijuana use among US residents aged 12-25: results from the 1979-2016 National Survey on drug use and health.
Yu B; Chen X; Chen X; Yan H
BMC Public Health; 2020 Feb; 20(1):156. PubMed ID: 32013937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
